Open AccessLinezolid-Induced Pancytopenia in Patients Using Dapagliflozin: A Case Series
Author(s) -
Meng Mei Li,
WeiTing Shen,
Yu Jin Li,
Jun Teng
Publication year - 2022
Publication title -
infection and drug resistance
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.033
H-Index - 39
ISSN - 1178-6973
DOI - 10.2147/idr.s375694
Subject(s) - linezolid , medicine , pancytopenia , discontinuation , pneumonia , surgery , gastroenterology , vancomycin , staphylococcus aureus , bone marrow , biology , bacteria , genetics
Linezolid is classed as oxazolidinone antibiotics which can be used to treat severe infections caused by vancomycin-resistant Enterococcus faecium, hospital-acquired pneumonia caused by Staphylococcus aureus, complicated skin, and uncomplicated skin structure infections (SSSIs) caused by methicillin-susceptible S. aureus or Streptococcus pyogenes, and community-acquired pneumonia caused by Streptococcus pneumoniae. However, many studies have suggested it can also cause thrombocytopenia and pancytopenia.